[HTML][HTML] Efectividad de las vacunas contra SARS-CoV-2 en hospitalizados con fallas vacunales en 10 hospitales de la CCINSHAE

…, A Mora-Pavón, CM Hernández-Cárdenas… - salud pública de …, 2022 - scielo.org.mx
Objetivo: Evaluar la efectividad de las vacunas contra SARS-CoV-2 para evitar muerte e
intubación en pacientes hospitalizados con Covid-19. Material y métodos: Se presentó un …

[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

…, AC Gordon, CM Hernandez-Cardenas… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …

[HTML][HTML] Clinical and immunological factors that distinguish COVID-19 from pandemic influenza A (H1N1)

…, EA Garcia-Latorre, CM Hernandez-Cardenas… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is a global health threat with the potential to cause …

Phase angle and overhydration are associated with post‐extubating dysphagia in patients with COVID‐19 discharged from the ICU

…, CM HernándezCárdenas… - Nutrition in Clinical …, 2022 - Wiley Online Library
Background Few studies have evaluated the prevalence of post‐extubation dysphagia and
associated factors in patients with coronavirus disease 2019 (COVID‐19) . Our study …

Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19

…, CM Hernández-Cárdenas… - Journal of Interferon & …, 2022 - liebertpub.com
Interferon-induced transmembrane (IFITM) proteins mediate protection against enveloped
viruses by blocking membrane fusion at endosomes. IFITM1 and IFITM3 are crucial for …

[HTML][HTML] CXCL17 is a specific diagnostic biomarker for severe pandemic influenza A (H1N1) that predicts poor clinical outcome

…, CM Hernández-Cárdenas… - Frontiers in …, 2021 - frontiersin.org
The CXC motif chemokine ligand 17 (CXCL17) is chemotactic for myeloid cells, exhibits
bactericidal activity, and exerts anti-viral functions. This chemokine is constitutively expressed in …

[HTML][HTML] Clinical risk factors for mortality among critically ill Mexican patients with COVID-19

CM Hernández-Cárdenas, JA Choreño-Parra… - Frontiers in …, 2021 - frontiersin.org
Little literature exists about critically ill patients with coronavirus disease 2019 (COVID-19)
from Latin America. Here, we aimed to describe the clinical characteristics and mortality risk …

[HTML][HTML] Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized …

…, AC Gordon, CM Hernandez-Cardenas… - Nature …, 2024 - nature.com
The original version of this article contained an error in Table 1, which misidentified the trial
included in the meta-analysis registered as NCT04323527 as CloroCOVID19II instead of …

[HTML][HTML] High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico

…, L Jiménez-Álvarez, CM Hernández-Cardenas… - International Journal of …, 2019 - Elsevier
Objectives To evaluate the performance of rapid influenza diagnostic tests (RIDT) and
influenza vaccines’ effectiveness (VE) during an outbreak setting. Methods We compared the …

Effectiveness of SARS-CoV-2 vaccines in hospitalized patients with vaccine failures in 10 CCINSHAE hospitals

…, A Mora-Pavón, CM Hernández-Cárdenas… - Salud Pública de …, 2022 - medigraphic.com
Objective. To evaluate the effectiveness of SARS-CoV-2 vaccines to avoid death and intubation
in hospitalized patients with Covid-19. Materials and methods. We present an analysis of …